[Percutaneous closure of persistent ductus arteriosus in low-weight infants]

M Hassine1, S Hamdi2, D Mlayeh1

  • 1Cardiology A department, university of Monastir, Fattouma Bourguiba university hospital, 5000 Monastir, Tunisie.

Insights

Percutaneous closure of persistent ductus arteriosus using the Amplatzer Duct Occluder is effective in infants under 6kg. This procedure shows a low complication rate, with significant clinical improvement observed post-intervention.

Area of Science:

  • Pediatric Cardiology
  • Interventional Cardiology
  • Congenital Heart Disease

Background:

  • Persistent ductus arteriosus (PDA) is a common congenital heart defect.
  • Surgical closure is standard, but percutaneous closure with the Amplatzer Duct Occluder is an alternative.
  • This device is typically not recommended for infants weighing less than 6kg.

Purpose of the Study:

  • To evaluate the efficacy and safety of the Amplatzer Duct Occluder for PDA closure in low-weight infants (<6kg).

Main Methods:

  • Retrospective analysis of medical records of infants <6kg who underwent PDA closure with the Amplatzer Duct Occluder (Jan 2010-Dec 2014).
  • Included 14 patients (mean weight 5.7kg).
  • Assessed procedural success, occlusion rates, complications, and clinical outcomes.

Main Results:

  • Successful implantation in 93% of cases; immediate occlusion rate was 71%.
  • Complications occurred in two patients (cardiac tamponade, partial disk protrusion).
  • PDA morphology (C-type) and PDA diameter/weight ratio >0.95 predicted failure; low weight (<6kg) did not predict failure. No late embolization.

Conclusions:

  • Percutaneous closure of PDA with the Amplatzer Duct Occluder is feasible and effective in infants weighing up to 6kg.
  • The procedure demonstrates a relatively low complication rate.
  • Significant clinical improvement, including pulmonary pressure normalization, was observed during follow-up.
Abstract

Related Concept Videos